California APRN Course Bundle

Contact Hours: 30

Pharmacology Hours: 12

Author(s):
  • Janice Tazbir RN, CS, CCRN, CNE, RYT
  • Edith Fomuso MSN, CCM, RN
  • Jillian Hay-Roe RNC-NIC
  • Amy White CNO, PRN
  • Maureen Sullivan MS, BSN, RN, CEN, CDE
  • Sarah Schulze MSN, NP
  • Michael York MSN, RN
  • Esther Van Baren MSN, RN
  • Joanne Kuplicki BSN, RN
  • Marian Oliver BSN, RNC, CMC, PMH-BC
  • Morgan Curry BSN, RN
  • Atana Collins MSN, RN, CDN
  • Daphne Day RN, SANE-A
  • Molina Allen RN
  • Lauren Stephanoff BSN, RN

Course Overview

In this course we will cover a variety of nursing topics which are listed in the course outline below. This course is appropriate for APRNs, RNs and LPNs. Upon completion of this single module you will receive a certificate for 30 contact hours, including 12 pharmacological contact hours.

Course Outline

  1. California Schedule II Controlled Substances and Risk of Addiction
  2. California Schedule II Controlled Substances and Neonatal Abstinence Syndrome
  3. Safe Prescribing of Opioids
  4. Tirzepatide for Type 2 Diabetes and Weight Management
  5. Semaglutide and Type 2 Diabetes
  6. Medication Assisted Treatment (MAT)
  7. Following a DNR: An Ethical Dilemma in Nursing
  8. Managing Conflict in a Nurse Leader Role
  9. A-fib and Stroke Risk
  10. Ethics for the Telehealth Nurse
  11. One Hour Sepsis Bundle
  12. Renal Failure Stages, Treatment, and Outcomes
  13. Screening for Suicide Risk Factors in Pediatrics
  14. Human Trafficking
  15. Pain Management in Nursing
  16. A Nurses Guide: How to Deal with Difficult Patients

Course Outcomes

After completing this course, the learner will rate 4 out of 5 on the Likert Scale for their ability to:

  1. Incorporate pharmacokinetic and pharmacodynamic principles of Schedule II medications to safely prescribe medications in the part of care for patients experiencing pain.
  2. Demonstrate an understanding of the pharmacokinetics and pharmacodynamics related to Schedule II controlled substances in relationship to women’s health and neonatal care.
  3. Describe factors when prescribing opioids, their indications, and their effects.
  4. Analyze the indications of usage for tirzepatide in diabetes and weight loss management.
  5. Discuss the long-term use of semaglutide injectables specific to the treatment of type 2 diabetes.
  6. Understand a nurse’s role in caring for patients receiving medication-assisted treatment.
  7. Explain what a DNR is and what it is not.
  8. Understand the risk assessment process for stroke in A-Fib.

Accreditations and Approvals

CE Credit Logo
  • American Nurses Credentialing Center (ANCC) (P0614)
  • California Board of Registered Nursing (CEP 17418)
  • Kentucky Board of Nursing (7-0090)
  • Louisiana State Board of Nursing (58)
  • Florida Board of Nursing (50-23983)
  • Delaware Board of Nursing (DE-24-010127)
  • Alabama Board of Nursing (#ABNP1577)
  • Iowa Board of Nursing (#393)
  • Kansas Board of Nursing (LT0340-0325)

Approved by the Board of Nursing in every state, you can complete your RN, LVN, and APRN CEUs with confidence.

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

It will take the average learner 1800 minutes to complete and awards 30 contact hours of continuing education.

Written For

  • Advanced Practice Registered Nurses (APRN)

Requirements for Completion

  1. Enrollment in the course by the learner
  2. Read and learn all course materials
  3. Complete the course evaluation
  4. Attest and testify learning of the course materials

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.